Our latest work on adherence-efficacy relationships of FTC/TDF-based HIV pre-exposure prophylaxis got published in Nature Medicine.
We provide compelling evidence that FTC/TDF-based PrEP works very well in protecting heterosexual women from HIV infection. Since FTC/TDF are cheap and available in resource-constrained settings, these findings could help establishing PrEP as a major pillar in preventing HIV transmission in heterosexual women; and ultimately empowering women to take control of HIV prevention.
See also related posts at Nature Medicine, Math+, RKI, IDW and on X (formerly twitter)
Leave a Reply